Position in CDXS
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$33,726
+$38 QoQ
Shares Held
20,691
+0.1% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BNP PARIBAS ARBITRAGE, SA holds $2,836,505,638 across 415 Biotechnology names. CDXS ranks #260 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
448,371 | $346,429,369 | |
| 2 | MRNA |
Moderna, Inc.
|
4,317,219 | $219,314,725 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
415,625 | $185,593,187 | |
| 4 | BNTX |
BioNTech SE
|
1,651,789 | $146,811,006 | |
| 5 | ARGX |
Argenx SE
|
177,836 | $129,864,739 | |
| 6 | INSM |
INSMED Inc
|
604,600 | $98,864,192 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,307,176 | $97,070,889 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
280,965 | $92,962,889 |
All Filings in CDXS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $33,726 | 20,691 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $33,688 | 20,668 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $40,523 | 16,608 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $20,910 | 8,570 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $13,573 | 5,046 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $47,590 | 9,977 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $42,386 | 13,762 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $319,358 | 103,019 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $355,180 | 101,771 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $55,921 | 18,335 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $132,226 | 69,961 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $405,739 | 144,907 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $605,065 | 146,151 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $785,182 | 168,494 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $620,974 | 102,471 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $420,450 | 40,196 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,270,447 | 110,109 | Shares | Defined | 2022-05-18 | |
| 2021-12-31 | $5,913,626 | 189,115 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $633,648 | 27,242 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $419,753 | 18,524 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $545,239 | 23,820 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $582,555 | 26,686 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $1,115,476 | 95,015 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $963,163 | 84,488 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $182,856 | 16,385 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||